Elite Pharmaceuticals, Inc.
ELTP · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $7 | $8 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $29 | $19 | $3 | $3 |
| Inventory | $16 | $13 | $10 | $7 |
| Other Curr. Assets | $1 | $1 | $0 | $0 |
| Total Curr. Assets | $58 | $40 | $22 | $19 |
| Property Plant & Equip (Net) | $14 | $15 | $10 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $6 | $6 | $7 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $18 | $22 | $2 | $2 |
| Other NC Assets | $0 | $1 | $0 | $0 |
| Total NC Assets | $39 | $44 | $19 | $16 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $96 | $84 | $41 | $35 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $1 |
| Short-Term Debt | $4 | $4 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $4 | $8 | $0 |
| Total Curr. Liab. | $12 | $13 | $8 | $7 |
| LT Debt | $3 | $3 | $4 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $25 | $6 | $1 | $1 |
| Total NC Liab. | $31 | $13 | $4 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $0 | $1 |
| Total Liabilities | $43 | $26 | $12 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$121 | -$116 | -$136 | -$140 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $54 | $58 | $29 | $25 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $96 | $84 | $41 | $35 |
| Net Debt | -$4 | $0 | -$4 | -$7 |